Nanologica is a Swedish life science tools company that provides input goods to pharmaceutical manufacturers. Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company’s mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments. The company is headquartered in Södertälje and Nanologica’s share (NICA) is listed for trading on Nasdaq Stockholm Main Market.

Bolagsstyrningsrapporter

Read more:

Bolagsstyrningsrapporter och revisorsyttranden

Bolagsstyrningsrapport 2022 Nanologica AB (publ)

Bolagsstyrningsrapport 2021 Nanologica AB (publ)

Bolagsstyrningsrapport 2020